Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2005 4
2006 4
2007 8
2008 16
2009 15
2010 15
2011 24
2012 11
2013 7
2014 8
2015 6
2016 12
2017 10
2018 9
2019 13
2020 11
2021 9
2022 10
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer.
Larsson P, Pettersson D, Olsson M, Sarathchandra S, Abramsson A, Zetterberg H, Ittner E, Forssell-Aronsson E, Kovács A, Karlsson P, Helou K, Parris TZ. Larsson P, et al. Among authors: karlsson p. Cell Death Discov. 2024 Jan 29;10(1):57. doi: 10.1038/s41420-024-01819-5. Cell Death Discov. 2024. PMID: 38286854 Free PMC article.
Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trial.
Alkner S, de Boniface J, Lundstedt D, Mjaaland I, Ryden L, Vikstrom J, Bendahl PO, Holmberg E, Sackey H, Wieslander E, Karlsson P. Alkner S, et al. Among authors: karlsson p. BMJ Open. 2023 Sep 26;13(9):e075543. doi: 10.1136/bmjopen-2023-075543. BMJ Open. 2023. PMID: 37751948 Free PMC article.
Reply to V. Nardone et al.
Sjöström M, Fyles A, Liu FF, McCready D, Feng FY, Speers CW, Pierce LJ, Holmberg E, Fernö M, Malmström P, Karlsson P. Sjöström M, et al. Among authors: karlsson p. J Clin Oncol. 2023 Aug 10;41(23):3959-3960. doi: 10.1200/JCO.23.00566. Epub 2023 Jun 6. J Clin Oncol. 2023. PMID: 37279434 No abstract available.
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial.
Stenmark Tullberg A, Sjöström M, Tran L, Niméus E, Killander F, Kovács A, Lundstedt D, Holmberg E, Karlsson P. Stenmark Tullberg A, et al. Among authors: karlsson p. J Immunother Cancer. 2023 May;11(5):e006618. doi: 10.1136/jitc-2022-006618. J Immunother Cancer. 2023. PMID: 37208129 Free PMC article. Clinical Trial.
188 results